NHS England is rolling out the one-off injection medication, nirsevimab, from late September to provide protection against RSV for eligible high-risk and very preterm babies who are born too early to ...

The approval for running MARS in the NHS trusts, foundation trusts and ICBs, is delegated to DHSC, by HM Treasury, annually (for each financial year). Each MARS is required to adhere to national model ...

If you are unable to notify within 36 hours (for example, due to an emergency), you must do so as soon as possible. If it is more than 36 hours since the birth, please contact ...